Roche Holding AG (RHHVF)
OTC
Closed
Aug 21, 2026
Day's Range
451.3052 wk Range
314.15Profile - RHHVF - Roche Holding AG
Profile
Mic Code
OTCQ
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
103.24K
Roche Holding AG is a Swiss biopharmaceutical and diagnostics company headquartered in Basel, Switzerland. The company develops, manufactures, and markets innovative medicines and diagnostic solutions worldwide, with a strong focus on oncology therapies derived from its integration with Genentech. Its bestselling pharmaceutical products target cancer treatment, while the diagnostics division provides centralized and point-of-care testing, bolstered by technologies in cell analysis, gene expression, genome sequencing, and nucleic acid purification. Oncology accounts for a significant portion of pharmaceutical sales, complemented by products serving researchers and healthcare providers. Roche Holding AG operates across healthcare sectors, including drug manufacturing and medical diagnostics, offering tools that support clinical decisions and research advancements. Founded in 1896, it maintains a prominent role in the global biopharmaceutical market through its diverse portfolio of blockbuster therapies and diagnostic innovations.
Profile Details
Type
Common Stock
Ceo
Mr. Zigurds R. Vitols
Address
Grenzacherstrasse 124
City
Basel
State
TX
Zip
4070
Country
Switzerland
Phone
41 61 688 88 80
Key Executives - RHHVF - Roche Holding AG
Key executives
Cross Listings - RHHVF - Roche Holding AG
Also listed on
The same company trading on other exchanges.
- ROGPVSE
- ROPSIX
- RHOAFSX, XDUS, XSTU, Munich
- 0QOKLSE
- ROPzCBOE
- 1ROGMTA
- ROP1NBMV
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
